ChEMBL22003
ChEMBL22003 is a potential phase separation modulator of ARV7 that can bind to the ARV7 binding sites. ChEMBL22003 has potential for use in the research of prostate cancer[1].
Product Specifications
CAS Number
152813-63-3
UNSPSC
12352005
Target
Androgen Receptor
Related Pathways
Vitamin D Related/Nuclear Receptor
Applications
Cancer-programmed cell death
Field of Research
Cancer
Smiles
CN(C1=NNN=N1)C2=CC(NC(N[C@@H]3N=C(C4=C(N(C3=O)C)C=CC=C4)C5=CC=CC=C5)=O)=CC=C2
Molecular Formula
C25H23N9O2
Molecular Weight
481.51
References & Citations
[1]Pantelis Karatzas, et al. Small Molecules Targeting the Structural Dynamics of AR-V7 Partially Disordered Proteins Using Deep Ensemble Docking. J Chem Theory Comput. 2025 Apr 15.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC400352-500 1x 500 µL
CD31 / PECAM-1 (158-2B3), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC680977-500 1x 500 µL
TGF-beta (1D11.16.8), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC682559-100 1x 100 µL
Human IgM (Immunoglobulin Mu Heavy Chain) (B-Cell Marker) (IGHM/2559R), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC472200-500 1x 500 µL
Cytokeratin 7 (Glandular and Transitional Epithelial Marker) (KRT7/2200), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details